Achieve Life Sciences (ACHV) 10-Q2005 Q1 Quarterly report

Filed: 10 May 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: Abraxane, absolute, accretion, accrued, accuracy, adjusted, Alan, alleged, alleging, American, amortization, amortized, analyzed, asserted, asserting, assuming, attacking, attainment, attributed, award, breach, breached, bulk, calculated, Chemistry, chosen, claim, CMC, commencement, commensurate, commonly, comprise, concept, conclusion, confidence, consenting, consideration, consulting, correlate, cycle, detected, duration, effort, employment, enable, encountered, endpoint, entity, enumerated, equipment, fee, forma, formal, fraud, Fuhrman, fundraising, half, incomplete, interval, IV, January, lab, lesser, letter, line, liquid, literature, locked, Martino, masked, matter, merit, met, Michael, mid, milestone, modification, move, mutually, Orphan, overhead, paid, paper, partnership, payroll, permit, permitted, permitting, person, persuasive, pivotal, point, portion, powered, preclude, President, pro, proceed, properly, published, recall, receipt, recommended, reconstitution, reference, refundable, rejected, relevance, relevant, resolved, restate, Restated, retrospective, Royalty, secondary, seizure, selected, Senior, specific, specifically, statistical, statistically, Stewart, streamline, structure, substantive, suggest, suggested, survival, suspension, target, tax, term, timeline, twelve, type, understood, unforeseen, unnecessary, unrealized, unvested, verbally, verified, Vice, vigorously, week, women, written

Removed: biotech, collaborate, collection, consumed, creating, demonstrated, depreciation, encourage, enrolling, evidenced, excellent, exist, explained, fact, filing, front, hypersensitivity, indirect, innovation, invested, obsolescence, SNDA, sort, suited, terminate, uncommon, unsuccessful

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ACHV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Certification Pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and U.S.C. Section 1350

I, Michael A. Martino, President and Chief Executive Officer of Sonus Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 10, 2005

	/s/ Michael A. Martino
	Michael A. Martino
	President and Chief Executive Officer